Stock screener

IONS

Conviction 0HealthcareScan · Thu, Sep 24, 2026

Ionis Pharmaceuticals Inc (IONS) closed at $43.79 (-0.32%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 12, -49.4% from its 52-week high, -45.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

IONS$43.79-0.32%
ResistanceSupportVol 14Insider sell
63 bars
4
3
Vol MA14 4.91M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
IONIS PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.ionis.com ↗
Price43.79
Change-0.32%
Gap-0.57%
Rel volume1.02×
Avg volume4.11M
Avg $ vol209.23M
SMA 2052.85
SMA 5055.05
SMA 20071.44
Price vs 50-20.45%
Price vs 200-38.70%
MA stackbearish
50/200 cross—
Supertrenddown · 50.98
RSI (14)27
MACD hist-0.97
MACD cross—
Stoch %K / %D5 / 6
ADX (14)43
+DI / −DI10 / 43
RSI divergenceBullish
MACD divergenceBullish
ATR %5.33%
ADR %4.28%
52w high86.50
52w low43.79
From 52w high-49.38%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width50.98%
%B0.16
Donchian pos3.83%
Donchian high63.48
Donchian low43.01
AVWAP (52w high)66.03
vs AVWAP high-33.68%
AVWAP (52w low)44.16
vs AVWAP low-0.83%
OBV trendDown
Chaikin MF (20)-0.27
Today vs 20d1.02×
Avg vol (14d)4.91M
Avg vol (20d)4.11M
Avg $ vol (20d)209.23M
Market cap7.28B
RS Rating12 / 99
RS 3m (vs SPY)-48.59%
RS 6m (vs SPY)-56.58%
RS line new highNo
Trend template0/8
Technical rank8.2
1 week-6.33%
1 month-31.12%
3 months-44.10%
6 months-39.77%
1 year-30.01%
YTD-45.04%
P/E-19.08
P/B16.55
P/S7.71
P/FCF-22.74
EPS-2.38
Div yield—
ROE-86.73%
ROA-12.74%
Debt/Eq4.00
Current7.89
EV/EBITDA—
Gross margin—
Net margin-40.41%
Rev growth33.83%
EPS growth15.97%
Price target84.00
Target upside91.82%
Analyst ratingBuy
Institutional120.37%
Ent. value8.69B
Revenue267.95M
Net income-114.65M
Gross profit—
Free cash flow-320.03M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out165.26M
Employees1.4K
ListedFri, May 17, 1991
Free float157.03M
Float %95.1%
Short interest20.92M
Days to cover9.2d
Short volume25.2%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.70 vs −$1.09
Last surprise+35.8% beat
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank8.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance62.98
Support53.53
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IONS

All disclosures →
No recent disclosed trades by Congress in IONS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IONS

InsiderSideShares
BENNETT C FRANK
EVP, Chief Scientific Officer · Common Stock · 2026-08-31
Acquire110
Birchler Brian
EVP, Corp and Development Ops · Common Stock · 2026-08-31
Acquire58
Monia Brett P
Chief Executive Officer · Common Stock · 2026-08-31
Acquire98
O'NEIL PATRICK R.
EVP CLO & General Counsel · Common Stock · 2026-08-31
Acquire63
HERMAN JOAN E
Director · Restricted Stock Unit · 2026-07-15
Exercise5.22K
HERMAN JOAN E
Director · Common Stock · 2026-07-15
Exercise5.22K
BERTHELSEN SPENCER R
Director · Common Stock · 2026-07-15
Exercise5.22K
BERTHELSEN SPENCER R
Director · Restricted Stock Unit · 2026-07-15
Exercise5.22K
HANTSON LUDWIG
Director · Restricted Stock Unit · 2026-07-15
Grant3.4K
Reikes Peter N
Director · Restricted Stock Unit · 2026-07-15
Grant3.4K

SEC filings

EDGAR filings in IONS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.